259 related articles for article (PubMed ID: 21187408)
1. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.
Boone DN; Qi Y; Li Z; Hann SR
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):632-7. PubMed ID: 21187408
[TBL] [Abstract][Full Text] [Related]
2. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity.
Zhang Q; Spears E; Boone DN; Li Z; Gregory MA; Hann SR
Proc Natl Acad Sci U S A; 2013 Jan; 110(3):978-83. PubMed ID: 23277542
[TBL] [Abstract][Full Text] [Related]
3. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
[TBL] [Abstract][Full Text] [Related]
4. The Myc-nucleophosmin-ARF network: a complex web unveiled.
Li Z; Hann SR
Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
[TBL] [Abstract][Full Text] [Related]
5. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
6. MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib.
Wirth M; Stojanovic N; Christian J; Paul MC; Stauber RH; Schmid RM; Häcker G; Krämer OH; Saur D; Schneider G
Nucleic Acids Res; 2014; 42(16):10433-47. PubMed ID: 25147211
[TBL] [Abstract][Full Text] [Related]
7. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
8. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
9. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
[TBL] [Abstract][Full Text] [Related]
10. The ARF tumor suppressor: keeping Myc on a leash.
Gregory MA; Qi Y; Hann SR
Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
[TBL] [Abstract][Full Text] [Related]
11. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
13. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
14. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
[TBL] [Abstract][Full Text] [Related]
15. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
16. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
17. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
18. Qualitative network modeling of the Myc-p53 control system of cell proliferation and differentiation.
Aguda BD; Kim Y; Kim HS; Friedman A; Fine HA
Biophys J; 2011 Nov; 101(9):2082-91. PubMed ID: 22067145
[TBL] [Abstract][Full Text] [Related]
19. Mediation of c-Myc-induced apoptosis by p53.
Hermeking H; Eick D
Science; 1994 Sep; 265(5181):2091-3. PubMed ID: 8091232
[TBL] [Abstract][Full Text] [Related]
20. Distinct thresholds govern Myc's biological output in vivo.
Murphy DJ; Junttila MR; Pouyet L; Karnezis A; Shchors K; Bui DA; Brown-Swigart L; Johnson L; Evan GI
Cancer Cell; 2008 Dec; 14(6):447-57. PubMed ID: 19061836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]